Trial Profile
Prospective study investigating plasma levels of telaprevir to predict response in Hepatitis C patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Therapeutic Use
- 07 Dec 2015 New trial record